Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Rebel Energy (RE) is an energy supplier on a mission to address inequality and provide everyone with easy access to clean and affordable energy, to eventually eliminate fuel poverty. RE claims that fuel poverty led to 16,500+ cold-related deaths in the UK in 2018. RE argues that as the UK home electricity market enters a phase of growth in a post-COVID world, it will be focused on offering reliable customer service and develop strategies that help people who are struggling with their electricity bills. The company has applied for a B Corporation accreditation. RE asserts that its customer support systems are automated and can handle multiple queries simultaneously. It plans to offer a weekly direct debit payment option. RE will use the investment to grow its business across different verticals.
days to go:
Expired
investment:
£503,810
Arro Money is a fast-growing money management company engaged in managing your money in a straightforward manner. Unlike traditional banking institutions, Arro uses exclusive technology that enables straightforward and hassle-free financial services. Through simple application, you can open personal or business accounts and manage your funds. Despite a few early-stage hiccups, the company has successfully opened over 42,000 accounts.
days to go:
Expired
investment:
£567,540
Gendius' has created intellin, an application through which people can track diabetes and make a good decision to reduce the risk of diabetes. It is on a mission to make sure that every person with diabetes knows their risk of complications and how to control them. The company has been launched across the EU with over 3,500 downloads in the EU and UK. In 2018, the company won £25K Momentum award to complete UX/UI research and, it has passed ISO27001. Recently, it has been invited to HIMSSHealth2.0 conference for the application's live demo.
days to go:
Expired
investment:
£518,630
QFinds is a purpose-built hiring tool that enables employers to easily and efficiently pre-screen candidates, conduct interviews and generate employment contracts. The company asserts that it is a UK government vetted 'Kickstart Scheme' representative and can get small businesses grants to hire interns having already processed over 100 job applications. QFinds claims that its app has been downloaded 2 million+ times garnering 24,000 reviews averaging 4.8/5 stars. QFinds also points out that bad hirings cost the UK up to £6.7 billion in turnover, productivity, and training. It seeks to change this and disrupt the £39 billion recruitment market. The company has partnered with notable entities like University College London, Kings College London and Brunel University London, intending to use them as strategic partners to increase job seekers signing up to and using its app. QFinds will use the investment to grow its business across different verticals.
days to go:
Expired
investment:
£222,866
Clim8 is a financial technology company that aims to move billions of pounds of investment into sectors such as clean energy, clean technology, sustainable food, smart mobility, and recycling. It is authorised by the Financial Conduct Authority (FCA). The company quotes United Nations data arguing that the World needs to invest $2.4 trillion every year into clean energy, from now until 2035, to meet climate change targets. Clim8 aims to capitalise on this objective. It launched its app on iOS and Android in private beta in October 2020 and then in the App Store in March 2021. It claims that its users have invested from £25 up to £97,000. The company has raised £5 million in venture capital to date, secured up to £2 million in airtime for equity from Channel 4 Ventures, and garnered a 4.8 star rating in the App Store, from a cumulative 100 reviews. The company will use the investment to accelerate user acquisition and launch new product offerings including pensions.
days to go:
Expired
investment:
£2,849,790
Chip is one of the fastest-growing Fintech companies in the UK. Chip has built an app that uses the user's banking app to make personalised decisions about their money. Its user base has doubled since its previous fundraising in 2018. The company has 153,000 accounts, and it has processed more than £130m of savings. ChipX is the company's revolutionary returns platform and it has a waiting list of more than 50,000 people. The company is a winner of the British Bank Award, 2 Crowdcube awards, and 1 World Banking Award. It has welcomed many management executives from Funding Circle, Monzo, and Purple Bricks. Chip is now scaling with market-leading returns on ChipX. It aims to build the biggest savings account in the world. With the proceeds, the company will double its team and expand ChipX in the €10 trillion European savings market.
days to go:
Expired
investment:
£3,768,260
